Patent details
91962
Product Name:
"Azilsartan medoxomil (INN) et un de ses sels pharmaceutiquement acceptable, y compris le sel de potassium"
Basic Information
- Publication number:
- 91962
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP057197378
- Legal Status:
- Active
- Application number:
- 91962
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/11/734/001-011et EU/1/11/735/001-011
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 07/12/2011
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
-
Dates
- Filing date:
- 21/03/2012
- First Marketing Authorization date:
- 07/12/2011
- Grant date:
- 21/05/2012
- Activation date:
- 23/02/2025
- Publication date:
- 21/05/2012
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 07/12/2026
- SPC Extension Expiration:
- 07/12/2026
- Rejection date:
- Withdrawal date:
Owner
- From:
- 21/03/2012
-
-
- Name:
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Address:
- 1-1, DOSHOMACHI 4-CHOME CHUO-KU OSAKA-SHI,, OSAKA 541-0045, Japan (JP)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 21/03/2012
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- KUROITA Takanobu
- Address:
- Japan (JP)
2
- Name:
- OJIMA Mami
- Address:
- Japan (JP)
3
- Name:
- SAKAMOTO Hiroki
- Address:
- Japan (JP)
Publication
Bulletin
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2025/04
- Publication date:
- 04/03/2025
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 21/01/2026
- Last Annual Fee Paid Number:
- 22
- Last Annual Fee Paid Amount:
- 420 Euro
- Payer:
- ANAQUA SERVICES (ANC. SGA2)
| Filing date |
Document type |
Number of pages |